Lack of strong immune selection pressure by the immunodominant, HLA-A*0201-restricted cytotoxic T lymphocyte response in chronic human immunodeficiency virus-1 infection

被引:145
作者
Brander, C
Hartman, KE
Trocha, AK
Jones, NG
Johnson, RP
Korber, B
Wentworth, P
Buchbinder, SP
Wolinsky, S
Walker, BD
Kalams, SA
机构
[1] Massachusetts Gen Hosp, AIDS Res Ctr, Boston, MA 02114 USA
[2] Massachusetts Gen Hosp, Infect Dis Unit, Boston, MA 02114 USA
[3] Harvard Univ, Sch Med, Boston, MA 02114 USA
[4] Harvard Univ, Sch Med, New England Reg Primate Ctr, Southborough, MA 01772 USA
[5] Los Alamos Natl Labs, Div Theoret, Los Alamos, NM USA
[6] Cytel Corp, San Diego, CA 92121 USA
[7] Dept Publ Hlth, AIDS Off, San Francisco, CA 94102 USA
[8] Northwestern Univ, Sch Med, Dept Med, Chicago, IL 60611 USA
关键词
AIDS; immunodominance; escape; variant; antigen processing;
D O I
10.1172/JCI2405
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Despite detailed analysis of the HIV-l-specific cytotoxic T lymphocyte response by various groups, its relation to viral load and viral sequence variation remains controversial. We analyzed HLA-A*0201 restricted cytotoxic T lymphocyte responses in 17 HIV-l-infected individuals with viral loads ranging from < 400 to 221,000 HIV RNA molecules per milliliter of plasma. In 13 out of 17 infected subjects, CTL responses against the SLYNTVATL epitope (p17 Gag; aa 77-85) were detectable, whereas two other HLA-A*0201 restricted epitopes (ILKEPVHGV, IV9; and VIYQYMDDL, VL9) were only recognized by six and five individuals out of 17 individuals tested, respectively. Naturally occurring variants of the SL9 epitope were tested for binding to HLA-A*0201 and for recognition by specific T cell clones generated from five individuals. Although these variants were widely recognized, they differed by up to 10,000-fold in terms of variant peptide concentrations required for lysis of target cells. A comparison of viral sequences derived from 10 HLA-A*0201-positive individuals to sequences obtained from 11 HLA-A*0201-negative individuals demonstrated only weak evidence for immune selective pressure and thus question the in vivo efficacy of inmunodominant CTL responses present during chronic HIV-1 infection.
引用
收藏
页码:2559 / 2566
页数:8
相关论文
共 67 条
[1]   INVITRO SELECTION OF LYMPHOCYTIC CHORIOMENINGITIS VIRUS ESCAPE MUTANTS BY CYTOTOXIC LYMPHOCYTES-T [J].
AEBISCHER, T ;
MOSKOPHIDIS, D ;
ROHRER, UH ;
ZINKERNAGEL, RM ;
HENGARTNER, H .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (24) :11047-11051
[2]   PEPTIDE-SYNTHESIS .2. PROCEDURES FOR SOLID-PHASE SYNTHESIS USING N-ALPHA-FLUORENYLMETHOXYCARBONYLAMINO-ACIDS ON POLYAMIDE SUPPORTS - SYNTHESIS OF SUBSTANCE-P AND OF ACYL CARRIER PROTEIN 65-74 DECAPEPTIDE [J].
ATHERTON, E ;
LOGAN, CJ ;
SHEPPARD, RC .
JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 1, 1981, (02) :538-546
[3]   CYTOTOXIC T-LYMPHOCYTE RESPONSE TO A WILD-TYPE HEPATITIS-B VIRUS EPITOPE IN PATIENTS CHRONICALLY INFECTED BY VARIANT VIRUSES CARRYING SUBSTITUTIONS WITHIN THE EPITOPE [J].
BERTOLETTI, A ;
COSTANZO, A ;
CHISARI, FV ;
LEVRERO, M ;
ARTINI, M ;
SETTE, A ;
PENNA, A ;
GIUBERTI, T ;
FIACCADORI, F ;
FERRARI, C .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (03) :933-943
[4]  
BODMER JG, 1995, TISSUE ANTIGENS, V46, P1
[5]   Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus [J].
Borrow, P ;
Lewicki, H ;
Wei, XP ;
Horwitz, MS ;
Peffer, N ;
Meyers, H ;
Nelson, JA ;
Gairin, JE ;
Hahn, BH ;
Oldstone, MBA ;
Shaw, GM .
NATURE MEDICINE, 1997, 3 (02) :205-211
[6]   VIRUS-SPECIFIC CD8+ CYTOTOXIC T-LYMPHOCYTE ACTIVITY ASSOCIATED WITH CONTROL OF VIREMIA IN PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION [J].
BORROW, P ;
LEWICKI, H ;
HAHN, BH ;
SHAW, GM ;
OLDSTONE, MBA .
JOURNAL OF VIROLOGY, 1994, 68 (09) :6103-6110
[7]   HUMAN CYTOMEGALOVIRUS-SPECIFIC CYTO-TOXIC T-CELLS - THEIR PRECURSOR FREQUENCY AND STAGE SPECIFICITY [J].
BORYSIEWICZ, LK ;
GRAHAM, S ;
HICKLING, JK ;
MASON, PD ;
SISSONS, JGP .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1988, 18 (02) :269-275
[8]  
BRANDER C, 1995, CLIN EXP IMMUNOL, V101, P107
[9]  
BRANDER C, 1996, HIV MOL IMMUNOLOGY D
[10]   Genetic diversity of HLA-A2: Evolutionary and functional significance [J].
Browning, M ;
Krausa, P .
IMMUNOLOGY TODAY, 1996, 17 (04) :165-170